Duke’s Office for Translation & Commercialization works with Duke innovators to get their inventions out of the university and into the market with maximal societal impact. Visit website.
News from Duke OTC | |
 | Interdisciplinarity and impact shine at Duke Research and Innovation Summit 2025 Published January 14, 2025 |
| Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs Published January 13, 2025 |
| Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platfo Published January 8, 2025 |
| Duke, UNC, and NC State academics get crash course in building startups Published December 20, 2024 |
| Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Published December 20, 2024 |
| Greenlight Health Data Solutions and Pattern Health Merge to Expand Healthcare, Life Sciences and Insurance Solutions Published December 13, 2024 |
| Invented at Duke 2024 showcases the past and present of innovation at Duke, promising a bright future Published November 26, 2024 |
